EFFECT OF DALCETRAPIB PLUS PRAVASTATIN ON LIPOPROTEIN METABOLISM IN DYSLIPIDEMIC PATIENTS: RESULTS OF A PHASE 2B DOSE-RANGING STUDY
Christie M. Ballantyne, Michael Miller, Eric J. Niesor, Tracy Burgess, David Kallend, Evan A. SteinVolume:
55
Year:
2010
Language:
english
DOI:
10.1016/s0735-1097(10)60445-7
File:
PDF, 63 KB
english, 2010